Table 1.
Methyl acrylate (µg/ml) | Methyl-acrylate only | Methyl acrylate + 10 mM glutathione simultaneously | Methyl acrylate treatment followed by posttreatment with 10 mM glutathione | Methyl acrylate + 10 µM 2-mercaptoethanol | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
RGDT | RSG | RTG | RGDT | RSG | RTG | RGDT | RSG | RTG | RGDT | RSG | RTG | |
0 (Vehicle control) | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
1.0 | 107.0 | 90.3 | 101.6 | 99.7 | 85.7 | 67.3 | 93.2 | 84.1 | 90.8 | 101.3 | 101.3 | 94.6 |
5.0 | 103.1 | 68.3 | 74.2 | 99.6 | 85.5 | 75.3 | 85.8 | 62.7 | 68.8 | 102.0 | 82.1 | 82.1 |
10.0 | 99.7 | 61.0 | 59.0 | 98.8 | 90.8 | 82.8 | 86.4 | 59.5 | 73.2 | 98.0 | 81.6 | 73.8 |
15.0 | 94.2 | 49.5 | 50.3 | 104.8 | 87.0 | 92.4 | 84.2 | 59.1 | 60.0 | 94.7 | 70.7 | 80.4 |
20.0 | 89.5 | 46.5 | 38.1 | 96.3 | 79.9 | 68.1 | 79.1 | 42.0 | 55.4 | 84.2 | 56.0 | 49.0 |
25.0 | 874 | 25.7 | 27.0 | 108.1 | 83.5 | 74.8 | 73.3 | 10.1 | 6.2 | 86.4 | 41.3 | 52.1 |
30.0 | 88.5 | n.c | n.c | 100.5 | 89.6 | 91.4 | 833 | 15.6 | 13.5 | 90.3 | 37.0 | 28.2 |
35.0 | 88.2 | n.c | n.c | 103.4 | 77 1 | 66.8 | 841 | 11.0 | 6.2 | 86.3 | 48.0 | 46.4 |
RGDT relative growth during treatment [%]; RSG relative suspension growth [%]; RTG relative total growth [%]; n.c. culture not continued due to strong cytotoxicity